(Q39749375)

14 September 2017

title

Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery (English)

1 reference

14 September 2017

0 references

1 reference

Effie L Gillespie

1

1 reference

14 September 2017

C Michael White

2

1 reference

14 September 2017

Jeffrey Kluger

3

1 reference

14 September 2017

James A Rancourt

4

1 reference

14 September 2017

Robert Gallagher

5

1 reference

14 September 2017

Craig I Coleman

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

14 September 2017

1 reference

14 September 2017

volume

26

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

499-504

1 reference

A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Uncertainty in decision models analyzing cost-effectiveness: the joint distribution of incremental costs and effectiveness evaluated with a nonparametric bootstrap method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.4.499

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.4.499

1 reference

14 September 2017

1 reference